Zynex (ZYXI) Competitors $2.35 -0.34 (-12.64%) Closing price 03:33 PM EasternExtended Trading$2.40 +0.05 (+2.34%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYXI vs. NNOX, ZIMV, SNWV, CATX, NYXH, DRTS, SMTI, BWAY, SKIN, and TCMDShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Nano-X Imaging (NNOX), ZimVie (ZIMV), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Sanara MedTech (SMTI), Brainsway (BWAY), Beauty Health (SKIN), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry. Zynex vs. Its Competitors Nano-X Imaging ZimVie Sanuwave Health Perspective Therapeutics Nyxoah Alpha Tau Medical Sanara MedTech Brainsway Beauty Health Tactile Systems Technology Nano-X Imaging (NASDAQ:NNOX) and Zynex (NASDAQ:ZYXI) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Is NNOX or ZYXI more profitable? Zynex has a net margin of -4.30% compared to Nano-X Imaging's net margin of -472.19%. Zynex's return on equity of -23.70% beat Nano-X Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-472.19% -30.92% -27.73% Zynex -4.30%-23.70%-6.23% Do insiders and institutionals hold more shares of NNOX or ZYXI? 21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 49.3% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger valuation and earnings, NNOX or ZYXI? Zynex has higher revenue and earnings than Nano-X Imaging. Zynex is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$11.28M27.02-$53.52M-$0.90-5.86Zynex$192.35M0.37$2.99M-$0.24-9.79 Which has more risk & volatility, NNOX or ZYXI? Nano-X Imaging has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Do analysts rate NNOX or ZYXI? Nano-X Imaging presently has a consensus target price of $9.50, suggesting a potential upside of 80.09%. Zynex has a consensus target price of $6.00, suggesting a potential upside of 155.32%. Given Zynex's higher possible upside, analysts clearly believe Zynex is more favorable than Nano-X Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer NNOX or ZYXI? In the previous week, Zynex had 8 more articles in the media than Nano-X Imaging. MarketBeat recorded 9 mentions for Zynex and 1 mentions for Nano-X Imaging. Zynex's average media sentiment score of 0.09 beat Nano-X Imaging's score of 0.00 indicating that Zynex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zynex 0 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryZynex beats Nano-X Imaging on 11 of the 16 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$81.34M$10.51B$5.54B$8.95BDividend YieldN/A2.09%5.38%4.08%P/E Ratio-9.7916.7427.4020.04Price / Sales0.3729.51419.46118.60Price / Cash11.0222.8436.6357.47Price / Book2.103.668.085.67Net Income$2.99M$235.40M$3.16B$248.47M7 Day Performance-9.96%1.89%2.12%2.90%1 Month Performance9.81%3.83%4.43%5.75%1 Year Performance-73.65%-10.20%35.62%21.36% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex2.6448 of 5 stars$2.35-12.6%$6.00+155.3%-70.3%$81.34M$192.35M-9.79770News CoverageAnalyst ForecastGap DownNNOXNano-X Imaging1.502 of 5 stars$5.17-1.1%$9.50+83.8%-22.2%$302.18M$11.28M0.00190ZIMVZimVie2.33 of 5 stars$9.35+1.0%$16.33+74.7%-44.8%$257.87M$449.75M11.721,770SNWVSanuwave HealthN/A$32.86+9.7%N/AN/A$256.24M$32.63M0.0040Positive NewsCATXPerspective Therapeutics1.9106 of 5 stars$3.44-8.5%$12.56+265.0%-67.7%$255.34MN/A0.0070NYXHNyxoah2.4745 of 5 stars$7.48+0.1%$14.50+93.9%+7.1%$254.43M$4.89M0.00110Positive NewsGap UpDRTSAlpha Tau Medical2.5378 of 5 stars$3.12+4.7%$8.00+156.4%+45.4%$252.76MN/A0.0080News CoverageSMTISanara MedTech1.9751 of 5 stars$28.39-0.1%$49.50+74.4%+8.1%$252.50M$86.67M0.0060BWAYBrainsway1.4323 of 5 stars$13.15-0.5%$14.25+8.4%+116.2%$249.79M$41.02M66.10120SKINBeauty Health0.3714 of 5 stars$1.91-2.1%$1.42-25.8%+7.7%$245.69M$334.30M0.001,030Trending NewsGap UpTCMDTactile Systems Technology2.9798 of 5 stars$10.14-1.9%$16.00+57.8%-10.5%$240.39M$292.98M14.561,037News CoveragePositive News Related Companies and Tools Related Companies Nano-X Imaging Alternatives ZimVie Alternatives Sanuwave Health Alternatives Perspective Therapeutics Alternatives Nyxoah Alternatives Alpha Tau Medical Alternatives Sanara MedTech Alternatives Brainsway Alternatives Beauty Health Alternatives Tactile Systems Technology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYXI) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
